Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 ANB-020
  • 1.3.3 ANN-004
  • 1.3.4 AR-101
  • 1.3.5 ASP-0892
  • 1.3.6 DBV-712
  • 1.3.7 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Peanut Allergy Therapeutics Market Share by Application (2019-2025)
  • 1.4.2 Clinic
  • 1.4.3 Hospital
  • 1.4.4 Home Care
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Peanut Allergy Therapeutics Market Size
  • 2.1.1 Global Peanut Allergy Therapeutics Revenue 2014-2025
  • 2.1.2 Global Peanut Allergy Therapeutics Sales 2014-2025
• 2.2 Peanut Allergy Therapeutics Growth Rate by Regions
  • 2.2.1 Global Peanut Allergy Therapeutics Sales by Regions 2014-2019
  • 2.2.2 Global Peanut Allergy Therapeutics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Peanut Allergy Therapeutics Sales by Manufacturers
  • 3.1.1 Peanut Allergy Therapeutics Sales by Manufacturers 2014-2019
  • 3.1.2 Peanut Allergy Therapeutics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Peanut Allergy Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Peanut Allergy Therapeutics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.3 Peanut Allergy Therapeutics Price by Manufacturers
• 3.4 Key Manufacturers Peanut Allergy Therapeutics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Peanut Allergy Therapeutics Market
• 3.6 Key Manufacturers Peanut Allergy Therapeutics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 ANB-020 Sales and Revenue (2014-2019)
  • 4.1.2 ANN-004 Sales and Revenue (2014-2019)
  • 4.1.3 AR-101 Sales and Revenue (2014-2019)
  • 4.1.4 ASP-0892 Sales and Revenue (2014-2019)
  • 4.1.5 DBV-712 Sales and Revenue (2014-2019)
  • 4.1.6 Others Sales and Revenue (2014-2019)
• 4.2 Global Peanut Allergy Therapeutics Sales Market Share by Type
• 4.3 Global Peanut Allergy Therapeutics Revenue Market Share by Type
• 4.4 Peanut Allergy Therapeutics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Peanut Allergy Therapeutics Sales by Application

6 United States

• 6.1 United States Peanut Allergy Therapeutics Breakdown Data by Company
• 6.2 United States Peanut Allergy Therapeutics Breakdown Data by Type
• 6.3 United States Peanut Allergy Therapeutics Breakdown Data by Application

7 European Union

• 7.1 European Union Peanut Allergy Therapeutics Breakdown Data by Company
• 7.2 European Union Peanut Allergy Therapeutics Breakdown Data by Type
• 7.3 European Union Peanut Allergy Therapeutics Breakdown Data by Application

8 China

• 8.1 China Peanut Allergy Therapeutics Breakdown Data by Company
• 8.2 China Peanut Allergy Therapeutics Breakdown Data by Type
• 8.3 China Peanut Allergy Therapeutics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Peanut Allergy Therapeutics Breakdown Data by Company
• 9.2 Rest of World Peanut Allergy Therapeutics Breakdown Data by Type
• 9.3 Rest of World Peanut Allergy Therapeutics Breakdown Data by Application
• 9.4 Rest of World Peanut Allergy Therapeutics Breakdown Data by Countries
  • 9.4.1 Rest of World Peanut Allergy Therapeutics Sales by Countries
  • 9.4.2 Rest of World Peanut Allergy Therapeutics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Adverum Biotechnologies Inc
  • 10.1.1 Adverum Biotechnologies Inc Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.1.4 Peanut Allergy Therapeutics Product Introduction
  • 10.1.5 Adverum Biotechnologies Inc Recent Development
• 10.2 Aimmune Therapeutics Inc
  • 10.2.1 Aimmune Therapeutics Inc Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.2.4 Peanut Allergy Therapeutics Product Introduction
  • 10.2.5 Aimmune Therapeutics Inc Recent Development
• 10.3 Alfacyte Ltd
  • 10.3.1 Alfacyte Ltd Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.3.4 Peanut Allergy Therapeutics Product Introduction
  • 10.3.5 Alfacyte Ltd Recent Development
• 10.4 Allergy Therapeutics Plc
  • 10.4.1 Allergy Therapeutics Plc Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.4.4 Peanut Allergy Therapeutics Product Introduction
  • 10.4.5 Allergy Therapeutics Plc Recent Development
• 10.5 AnaptysBio Inc
  • 10.5.1 AnaptysBio Inc Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.5.4 Peanut Allergy Therapeutics Product Introduction
  • 10.5.5 AnaptysBio Inc Recent Development
• 10.6 ASIT Biotech SA
  • 10.6.1 ASIT Biotech SA Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.6.4 Peanut Allergy Therapeutics Product Introduction
  • 10.6.5 ASIT Biotech SA Recent Development
• 10.7 Astellas Pharma Inc
  • 10.7.1 Astellas Pharma Inc Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.7.4 Peanut Allergy Therapeutics Product Introduction
  • 10.7.5 Astellas Pharma Inc Recent Development
• 10.8 BioLingus AG
  • 10.8.1 BioLingus AG Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.8.4 Peanut Allergy Therapeutics Product Introduction
  • 10.8.5 BioLingus AG Recent Development
• 10.9 DBV Technologies SA
  • 10.9.1 DBV Technologies SA Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.9.4 Peanut Allergy Therapeutics Product Introduction
  • 10.9.5 DBV Technologies SA Recent Development
• 10.10 HAL Allergy BV
  • 10.10.1 HAL Allergy BV Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Peanut Allergy Therapeutics
  • 10.10.4 Peanut Allergy Therapeutics Product Introduction
  • 10.10.5 HAL Allergy BV Recent Development
• 10.11 Intrommune Therapeutics
• 10.12 Sanofi
• 10.13 Selecta Biosciences Inc

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Peanut Allergy Therapeutics Sales Channels
  • 11.2.2 Peanut Allergy Therapeutics Distributors
• 11.3 Peanut Allergy Therapeutics Customers

12 Market Forecast

• 12.1 Global Peanut Allergy Therapeutics Sales and Revenue Forecast 2019-2025
• 12.2 Global Peanut Allergy Therapeutics Sales Forecast by Type
• 12.3 Global Peanut Allergy Therapeutics Sales Forecast by Application
• 12.4 Peanut Allergy Therapeutics Forecast by Regions
  • 12.4.1 Global Peanut Allergy Therapeutics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Peanut Allergy Therapeutics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Peanut Allergy Therapeutics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peanut Allergy Therapeutics.

This report studies the global market size of Peanut Allergy Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Peanut Allergy Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Adverum Biotechnologies Inc
Aimmune Therapeutics Inc
Alfacyte Ltd
Allergy Therapeutics Plc
AnaptysBio Inc
ASIT Biotech SA
Astellas Pharma Inc
BioLingus AG
DBV Technologies SA
HAL Allergy BV
Intrommune Therapeutics
Sanofi
Selecta Biosciences Inc

Market Segment by Product Type
ANB-020
ANN-004
AR-101
ASP-0892
DBV-712
Others

Market Segment by Application
Clinic
Hospital
Home Care

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Peanut Allergy Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Peanut Allergy Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Peanut Allergy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025